Don’t miss our content
SubscribeCuatrecasas has advised Aleos Capital, a Spanish private equity firm, on acquiring a majority stake in Eggnovo. This transaction constitutes the first investment made by Aleos Capital through its fund and marks the beginning of its investment activity.
With over a decade of experience and a strong commitment to the circular economy that is part of the company's DNA, Eggnovo produces natural ingredients extracted from eggshell membranes for the food, health, and cosmetics industries. From this membrane, the company develops ingredients that combine compounds including collagen, hyaluronic acid, and elastin, especially suited to support joint health, skin care, and overall well-being. Also, through sustainable processes, Eggnovo obtains highly bioavailable calcium carbonate from eggshells, an ideal ingredient for formulations targeting bone health and a wide range of industrial applications.
Eggnovo is a rapidly growing company with a significant international presence. The transaction will allow it to boost its growth, strengthen its international expansion, and consolidate its position in the market for natural ingredients intended for nutraceutical, cosmetic, veterinary, and food applications.
The Cuatrecasas team handling the advisory services was made up of lawyers Francisco Martínez Maroto, Pedro López-Dóriga, Catalina Guzmán, Leticia García-Gallardo, Rocío Quintanilla, and Pablo Castillo from the Corporate and M&A Practice.
Don’t miss our content
Subscribe